{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:17:20Z","timestamp":1794467840986,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer (CC) remains a significant global health challenge despite advancements in screening, HPV vaccination, and therapeutic strategies. Tumor heterogeneity, driven by epigenetic modifications, affects immune evasion, metastasis, and treatment response. Cancer-associated fibroblasts (CAFs) play a crucial role in CC progression and therapy resistance. Single-cell sequencing offers new insights but remains underutilized in CC research. This study integrates single-cell RNA sequencing (scRNA-seq), spatial transcriptomics, and deconvolution analysis to identify key genes and immunotherapy targets. By constructing a prognostic model and exploring the immune microenvironment, we aim to provide novel insights into CC pathogenesis and potential therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized scRNA-seq, spatial transcriptomics, deconvolution analysis, and pseudotime trajectory mapping to delineate fibroblast subtypes within the tumor immune microenvironment (TIME) of CC. Functional annotations, differential gene expression profiling, cell\u2013cell communication pathways, and transcription factor networks were systematically analyzed. A prognostic model based on bulk RNA-seq data was constructed and validated through survival analysis, with correlations to immune microenvironment characteristics. Functional experiments investigated the role of SDC1, a critical mediator of fibroblast-tumor crosstalk. Additionally, Fibroblast\u2013tumor cell co-culture systems and functional assays were employed to investigate the paracrine role of SDC1. The CAF MYH11\u207a subpopulation was isolated via fluorescence-activated cell sorting (FACS). Multiplex immunofluorescence and immunohistochemical analyses were performed on both cultured cells and human cervical cancer tissue samples to characterize the spatial distribution and dynamic remodeling of MYH11 during stromal reorganization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six distinct fibroblast subtypes were identified, including the C0 MYH11\u2009+\u2009fibroblasts, which exhibited unique roles in stemness maintenance, metabolic activity, and immune regulation. Spatial and functional analyses revealed that the C0 subtype is central to tumor-fibroblast interactions, particularly through the MDK-SDC1 signaling axis. The prognostic model incorporating fibroblast-specific markers demonstrated robust predictive power for patient survival outcomes. Additionally, in vitro SDC1 knockdown significantly inhibited CC cell proliferation, migration, and invasion. Fibroblasts show spatially regulated heterogeneity, with activation markers enriched in the tumor zone and MYH11 highest in normal zones, indicating dynamic stromal remodeling. C0 MYH11\u2009+\u2009CAF Promotes Tumor Cell Proliferation, Migration, and Inhibits Apoptosis via Soluble SDC1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results illustrate, in some ways, the possible immunomodulatory and tumor supporting roles of CAFs in CC TIME and highlight the possibility that the MDK-SDC1 pathway is a promising therapeutic target. This study not only promotes a partially new understanding of temporal heterogeneity in CC, but also provides a possible reference base for the development of new biomarkers and immunotherapy approaches to improve clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03432-5","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T22:44:53Z","timestamp":1751669093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Deciphering the tumor immune microenvironment: single-cell and spatial transcriptomic insights into cervical cancer fibroblasts"],"prefix":"10.1186","volume":"44","author":[{"given":"Zhiheng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengjie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuxi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"3432_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-CANCER J CLIN. 2024;74:229\u201363.","journal-title":"CA-CANCER J CLIN"},{"key":"3432_CR2","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F, Vaccarella S. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. LANCET GLOB HEALTH. 2023;11:e197-206.","journal-title":"LANCET GLOB HEALTH"},{"key":"3432_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40364-022-00428-7","volume":"10","author":"Q Sun","year":"2022","unstructured":"Sun Q, Wang L, Zhang C, Hong Z, Han Z. Cervical cancer heterogeneity: a constant battle against viruses and drugs. BIOMARK RES. 2022;10:85.","journal-title":"BIOMARK RES"},{"key":"3432_CR4","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1158\/0008-5472.CAN-20-0521","volume":"80","author":"L Geistlinger","year":"2020","unstructured":"Geistlinger L, Oh S, Ramos M, Schiffer L, LaRue RS, Henzler CM, Munro SA, Daughters C, Nelson AC, Winterhoff BJ, Chang Z, Talukdar S, Shetty M, Mullany SA, Morgan M, Parmigiani G, Birrer MJ, Qin LX, Riester M, Starr TK, Waldron L. Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma. CANCER RES. 2020;80:4335\u201345.","journal-title":"CANCER RES"},{"key":"3432_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcancer.2019.07.008","volume":"63","author":"CJ Pelham","year":"2020","unstructured":"Pelham CJ, Nagane M, Madan E. Cell competition in tumor evolution and heterogeneity: Merging past and present. SEMIN CANCER BIOL. 2020;63:11\u20138.","journal-title":"SEMIN CANCER BIOL"},{"key":"3432_CR6","doi-asserted-by":"publisher","first-page":"eadd8977","DOI":"10.1126\/sciadv.add8977","volume":"9","author":"C Liu","year":"2023","unstructured":"Liu C, Zhang M, Yan X, Ni Y, Gong Y, Wang C, Zhang X, Wan L, Yang H, Ge C, Li Y, Zou W, Huang R, Li X, Sun B, Liu B, Yue J, Yu J. Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression. SCI ADV. 2023;9:eadd8977.","journal-title":"SCI ADV"},{"key":"3432_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41392-022-01264-9","volume":"8","author":"C Liu","year":"2023","unstructured":"Liu C, Li X, Huang Q, Zhang M, Lei T, Wang F, Zou W, Huang R, Hu X, Wang C, Zhang X, Sun B, Xing L, Yue J, Yu J. Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer. SIGNAL TRANSDUCT TAR. 2023;8:44.","journal-title":"SIGNAL TRANSDUCT TAR"},{"key":"3432_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ijc.10627","volume":"101","author":"A Zhang","year":"2002","unstructured":"Zhang A, Maner S, Betz R, Angstrom T, Stendahl U, Bergman F, Zetterberg A, Wallin KL. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. INT J CANCER. 2002;101:427\u201333.","journal-title":"INT J CANCER"},{"key":"3432_CR9","doi-asserted-by":"publisher","first-page":"9852","DOI":"10.1128\/JVI.77.18.9852-9861.2003","volume":"77","author":"HR McMurray","year":"2003","unstructured":"McMurray HR, McCance DJ. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J VIROL. 2003;77:9852\u201361.","journal-title":"J VIROL"},{"key":"3432_CR10","first-page":"188894","volume":"1878","author":"H Liu","year":"2023","unstructured":"Liu H, Ma H, Li Y, Zhao H. Advances in epigenetic modifications and cervical cancer research. BBA-REV CANCER. 2023;1878: 188894.","journal-title":"BBA-REV CANCER"},{"key":"3432_CR11","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1038\/s41416-024-02877-3","volume":"131","author":"Y Hirahara","year":"2024","unstructured":"Hirahara Y, Shimizu K, Yamasaki S, Iyoda T, Ueda S, Sato S, Harada J, Saji H, Fujii S, Miyagi Y, Miyagi E, Fujii SI. Crucial immunological roles of the invasion front in innate and adaptive immunity in cervical cancer. BRIT J CANCER. 2024;131:1762\u201374.","journal-title":"BRIT J CANCER"},{"key":"3432_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.18632\/genesandcancer.15","volume":"5","author":"P Zhang","year":"2014","unstructured":"Zhang P, Li H, Yang B, Yang F, Zhang LL, Kong QY, Chen XY, Wu ML, Liu J. Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells. Genes Cancer. 2014;5:154\u201364.","journal-title":"Genes Cancer"},{"key":"3432_CR13","doi-asserted-by":"publisher","first-page":"7423","DOI":"10.1038\/s41598-025-91711-8","volume":"15","author":"T Amemiya","year":"2025","unstructured":"Amemiya T, Shuto S, Fujita I, Shibata K, Nakamura K, Watanabe M, Yamaguchi T. Causal interaction of metabolic oscillations in monolayers of Hela cervical cancer cells: emergence of complex networks. SCI REP-UK. 2025;15:7423.","journal-title":"SCI REP-UK"},{"key":"3432_CR14","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cell.2020.07.017","volume":"182","author":"A Maynard","year":"2020","unstructured":"Maynard A, McCoach CE, Rotow JK, Harris L, Haderk F, Kerr DL, Yu EA, Schenk EL, Tan W, Zee A, Tan M, Gui P, Lea T, Wu W, Urisman A, Jones K, Sit R, Kolli PK, Seeley E, Gesthalter Y, Le DD, Yamauchi KA, Naeger DM, Bandyopadhyay S, Shah K, Cech L, Thomas NJ, Gupta A, Gonzalez M, Do H, Tan L, Bacaltos B, Gomez-Sjoberg R, Gubens M, Jahan T, Kratz JR, Jablons D, Neff N, Doebele RC, Weissman J, Blakely CM, Darmanis S, Bivona TG. Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing. Cell. 2020;182:1232\u201351.","journal-title":"Cell"},{"key":"3432_CR15","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41588-020-00726-6","volume":"52","author":"GS Kinker","year":"2020","unstructured":"Kinker GS, Greenwald AC, Tal R, Orlova Z, Cuoco MS, McFarland JM, Warren A, Rodman C, Roth JA, Bender SA, Kumar B, Rocco JW, Fernandes P, Mader CC, Keren-Shaul H, Plotnikov A, Barr H, Tsherniak A, Rozenblatt-Rosen O, Krizhanovsky V, Puram SV, Regev A, Tirosh I. Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. NAT GENET. 2020;52:1208\u201318.","journal-title":"NAT GENET"},{"key":"3432_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41575-021-00471-z","volume":"18","author":"J Han","year":"2021","unstructured":"Han J, DePinho RA, Maitra A. Single-cell RNA sequencing in pancreatic cancer. NAT REV GASTRO HEPAT. 2021;18:451\u20132.","journal-title":"NAT REV GASTRO HEPAT"},{"key":"3432_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/15384101.2017.1281486","volume":"16","author":"T Murata","year":"2017","unstructured":"Murata T, Mekada E, Hoffman RM. Reconstitution of a metastatic-resistant tumor microenvironment with cancer-associated fibroblasts enables metastasis. Cell Cycle. 2017;16:533\u20135.","journal-title":"Cell Cycle"},{"key":"3432_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/JCMA.0000000000001129","volume":"87","author":"ZL Liu","year":"2024","unstructured":"Liu ZL, Chen N, Li R, Ma YJ, Qiayimaerdan A, Ma CL. WGCNA reveals a biomarker for cancer-associated fibroblasts to predict prognosis in cervical cancer. J CHIN MED ASSOC. 2024;87:885\u201397.","journal-title":"J CHIN MED ASSOC"},{"key":"3432_CR19","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjose S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. LANCET GLOB HEALTH. 2020;8:e191-203.","journal-title":"LANCET GLOB HEALTH"},{"key":"3432_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA-CANCER J CLIN. 2021;71:209\u201349.","journal-title":"CA-CANCER J CLIN"},{"key":"3432_CR21","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/ijc.30152","volume":"139","author":"A Castanon","year":"2016","unstructured":"Castanon A, Landy R, Sasieni PD. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix? INT J CANCER. 2016;139:1040\u20135.","journal-title":"INT J CANCER"},{"key":"3432_CR22","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/cid\/ciab561","volume":"74","author":"AF Rositch","year":"2022","unstructured":"Rositch AF, Levinson K, Suneja G, Monterosso A, Schymura MJ, McNeel TS, Horner MJ, Engels E, Shiels MS. Epidemiology of Cervical Adenocarcinoma and Squamous Cell Carcinoma Among Women Living With Human Immunodeficiency Virus Compared With the General Population in the United States. CLIN INFECT DIS. 2022;74:814\u201320.","journal-title":"CLIN INFECT DIS"},{"key":"3432_CR23","doi-asserted-by":"crossref","unstructured":"Sausen DG, Shechter O, Gallo ES, Dahari H, Borenstein R. Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications. Cancers. 2023;15(14):3692.","DOI":"10.3390\/cancers15143692"},{"key":"3432_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1634\/theoncologist.2002-0342","volume":"7","author":"M Friedlander","year":"2002","unstructured":"Friedlander M, Grogan M. Guidelines for the treatment of recurrent and metastatic cervical cancer. ONCOLOGIST. 2002;7:342\u20137.","journal-title":"ONCOLOGIST"},{"key":"3432_CR25","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","volume":"36","author":"S Gupta","year":"2018","unstructured":"Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri CS, Kerkar R, Engineer R, Tongaonkar H, Ghosh J, Gulia S, Kumar N, Shylasree TS, Gawade R, Kembhavi Y, Gaikar M, Menon S, Thakur M, Shrivastava S, Badwe R. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial. J CLIN ONCOL. 2018;36:1548\u201355.","journal-title":"J CLIN ONCOL"},{"key":"3432_CR26","doi-asserted-by":"publisher","first-page":"146824","DOI":"10.1016\/j.gene.2022.146824","volume":"844","author":"W Sun","year":"2022","unstructured":"Sun W, Hang D, Han S, Fu S, Ma H, Dong X, Xu Y, Li N, Hu Z. Construction of circRNA-associated ceRNA network reveals the regulation of fibroblast proliferation in cervical cancer. Gene. 2022;844: 146824.","journal-title":"Gene"},{"key":"3432_CR27","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1111\/febs.16331","volume":"289","author":"HA Mahmood","year":"2022","unstructured":"Mahmood HA, Tomas BE, Walker AJ, Grose RP, Chioni AM. FGF signalling facilitates cervical cancer progression. FEBS J. 2022;289:3440\u201356.","journal-title":"FEBS J"},{"key":"3432_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1159\/000490562","volume":"83","author":"L Guo","year":"2018","unstructured":"Guo L, Zhao A, Zhang R, Xie Y, Xu X. Study on the Association between the Fibroblast Growth Factor Receptor 4 Expression and High-Risk Human Papillomavirus Infection in Cervical Cancer and Precancerous Lesions. GYNECOL OBSTET INVES. 2018;83:608\u201314.","journal-title":"GYNECOL OBSTET INVES"},{"key":"3432_CR29","doi-asserted-by":"publisher","unstructured":"Zhang QH, Xu P, Lu YX, Dou HT. Acidic and basic fibroblast growth factor expression levels in cervical cancer and their effects on tumor cell proliferation. Genet Mol Res. 2016;15(4). https:\/\/doi.org\/10.4238\/gmr15049043.","DOI":"10.4238\/gmr15049043"},{"key":"3432_CR30","first-page":"331","volume":"36","author":"R Kawase","year":"2010","unstructured":"Kawase R, Ishiwata T, Matsuda Y, Onda M, Kudo M, Takeshita T, Naito Z. Expression of fibroblast growth factor receptor 2 IIIc in human uterine cervical intraepithelial neoplasia and cervical cancer. INT J ONCOL. 2010;36:331\u201340.","journal-title":"INT J ONCOL"},{"key":"3432_CR31","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.ccell.2021.09.003","volume":"39","author":"H Hu","year":"2021","unstructured":"Hu H, Piotrowska Z, Hare PJ, Chen H, Mulvey HE, Mayfield A, Noeen S, Kattermann K, Greenberg M, Williams A, Riley AK, Wilson JJ, Mao YQ, Huang RP, Banwait MK, Ho J, Crowther GS, Hariri LP, Heist RS, Kodack DP, Pinello L, Shaw AT, Mino-Kenudson M, Hata AN, Sequist LV, Benes CH, Niederst MJ, Engelman JA. Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms. Cancer Cell. 2021;39:1531\u201347.","journal-title":"Cancer Cell"},{"key":"3432_CR32","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1158\/2159-8290.CD-20-1484","volume":"12","author":"KM McAndrews","year":"2022","unstructured":"McAndrews KM, Chen Y, Darpolor JK, Zheng X, Yang S, Carstens JL, Li B, Wang H, Miyake T, Correa DSP, Kirtley ML, Natale M, Wu CC, Sugimoto H, LeBleu VS, Kalluri R. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer. CANCER DISCOV. 2022;12:1580\u201397.","journal-title":"CANCER DISCOV"},{"key":"3432_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ccell.2022.01.004","volume":"40","author":"AM Nicolas","year":"2022","unstructured":"Nicolas AM, Pesic M, Engel E, Ziegler PK, Diefenhardt M, Kennel KB, Buettner F, Conche C, Petrocelli V, Elwakeel E, Weigert A, Zinoveva A, Fleischmann M, Haupl B, Karakutuk C, Bohnenberger H, Mosa MH, Kaderali L, Gaedcke J, Ghadimi M, Rodel F, Arkan MC, Oellerich T, Rodel C, Fokas E, Greten FR. Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer. Cancer Cell. 2022;40:168\u201384.","journal-title":"Cancer Cell"},{"key":"3432_CR34","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","volume":"39","author":"S Affo","year":"2021","unstructured":"Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, Chin L, Filliol A, Wen W, Song X, Decker A, Worley J, Caviglia JM, Yu L, Yin D, Saito Y, Savage T, Wells RG, Mack M, Zender L, Arpaia N, Remotti HE, Rabadan R, Sims P, Leblond AL, Weber A, Riener MO, Stockwell BR, Gaublomme J, Llovet JM, Kalluri R, Michalopoulos GK, Seki E, Sia D, Chen X, Califano A, Schwabe RF. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell. 2021;39:866\u201382.","journal-title":"Cancer Cell"},{"key":"3432_CR35","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41467-019-14134-w","volume":"11","author":"F Pelon","year":"2020","unstructured":"Pelon F, Bourachot B, Kieffer Y, Magagna I, Mermet-Meillon F, Bonnet I, Costa A, Givel AM, Attieh Y, Barbazan J, Bonneau C, Fuhrmann L, Descroix S, Vignjevic D, Silberzan P, Parrini MC, Vincent-Salomon A, Mechta-Grigoriou F. Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms. NAT COMMUN. 2020;11:404.","journal-title":"NAT COMMUN"},{"key":"3432_CR36","doi-asserted-by":"publisher","first-page":"e110757","DOI":"10.15252\/embj.2022110757","volume":"42","author":"G Cao","year":"2023","unstructured":"Cao G, Yue J, Ruan Y, Han Y, Zhi Y, Lu J, Liu M, Xu X, Wang J, Gu Q, Wen X, Gao J, Zhang Q, Kang J, Wang C, Li F. Single-cell dissection of cervical cancer reveals key subsets of the tumor immune microenvironment. EMBO J. 2023;42: e110757.","journal-title":"EMBO J"},{"key":"3432_CR37","doi-asserted-by":"publisher","first-page":"e28857","DOI":"10.1002\/jmv.28857","volume":"95","author":"C Li","year":"2023","unstructured":"Li C, Liu D, Zhao Y, Ding Y, Hua K. Diverse intratumoral heterogeneity and immune microenvironment of two HPV-related cervical cancer types revealed by single-cell RNA sequencing. J MED VIROL. 2023;95: e28857.","journal-title":"J MED VIROL"},{"key":"3432_CR38","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1186\/s12885-021-08212-w","volume":"21","author":"P Jiang","year":"2021","unstructured":"Jiang P, Cao Y, Gao F, Sun W, Liu J, Ma Z, Xie M, Fu S. SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma. BMC Cancer. 2021;21:694.","journal-title":"BMC Cancer"},{"key":"3432_CR39","doi-asserted-by":"publisher","first-page":"9872","DOI":"10.1080\/21655979.2022.2062088","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Wang D, Wei Q, Li C, Li C, Yang J. Long non-coding RNAs PGM5-AS1 upregulates Decorin (DCN) to inhibit cervical cancer progression by sponging miR-4284. Bioengineered. 2022;13:9872\u201384.","journal-title":"Bioengineered"},{"key":"3432_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40709-021-00151-8","volume":"28","author":"X Huang","year":"2021","unstructured":"Huang X, Shi H, Shi X, Jiang X. LncRNA FBXL19-AS1 promotes proliferation and metastasis of cervical cancer through upregulating COL1A1 as a sponge of miR-193a-5p. J BIOL RES-THESSALON. 2021;28:20.","journal-title":"J BIOL RES-THESSALON"},{"key":"3432_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12935-017-0443-5","volume":"17","author":"S Liu","year":"2017","unstructured":"Liu S, Liao G, Li G. Regulatory effects of COL1A1 on apoptosis induced by radiation in cervical cancer cells. CANCER CELL INT. 2017;17:73.","journal-title":"CANCER CELL INT"},{"key":"3432_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4143\/crt.2014.46.3.297","volume":"46","author":"Q Li","year":"2014","unstructured":"Li Q, Liu L, Zhang Q, Liu S, Ge D, You Z. Interleukin-17 Indirectly Promotes M2 Macrophage Differentiation through Stimulation of COX-2\/PGE2 Pathway in the Cancer Cells. CANCER RES TREAT. 2014;46:297\u2013306.","journal-title":"CANCER RES TREAT"},{"key":"3432_CR43","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3892\/etm.2021.10726","volume":"22","author":"Y Bai","year":"2021","unstructured":"Bai Y, Li H, Lv R. Interleukin-17 activates JAK2\/STAT3, PI3K\/Akt and nuclear factor-kappaB signaling pathway to promote the tumorigenesis of cervical cancer. EXP THER MED. 2021;22:1291.","journal-title":"EXP THER MED"},{"key":"3432_CR44","first-page":"7163","volume":"15","author":"L Li","year":"2018","unstructured":"Li L, Liu J, Liu C, Lu X. The correlation between TNF-alpha-308 gene polymorphism and susceptibility to cervical cancer. ONCOL LETT. 2018;15:7163\u20137.","journal-title":"ONCOL LETT"},{"key":"3432_CR45","doi-asserted-by":"publisher","first-page":"5679966","DOI":"10.1155\/2023\/5679966","volume":"2023","author":"X Chen","year":"2023","unstructured":"Chen X, Lin L, Wu Q, Li S, Wang H, Sun Y. Tumor Necrosis Factor-alpha Promotes the Tumorigenesis, Lymphangiogenesis, and Lymphatic Metastasis in Cervical Cancer via Activating VEGFC-Mediated AKT and ERK Pathways. MEDIAT INFLAMM. 2023;2023:5679966.","journal-title":"MEDIAT INFLAMM"},{"key":"3432_CR46","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s13277-012-0408-1","volume":"33","author":"G Barbisan","year":"2012","unstructured":"Barbisan G, Perez LO, Contreras A, Golijow CD. TNF-alpha and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol. 2012;33:1549\u201356.","journal-title":"Tumour Biol"},{"key":"3432_CR47","doi-asserted-by":"publisher","first-page":"854615","DOI":"10.3389\/fonc.2022.854615","volume":"12","author":"Y Ma","year":"2022","unstructured":"Ma Y, Zhang X, Yang J, Jin Y, Xu Y, Qiu J. Comprehensive Molecular Analyses of a TNF Family-Based Gene Signature as a Potentially Novel Prognostic Biomarker for Cervical Cancer. FRONT ONCOL. 2022;12: 854615.","journal-title":"FRONT ONCOL"},{"key":"3432_CR48","first-page":"157","volume":"13","author":"B Wang","year":"2020","unstructured":"Wang B, Wang M, Li X, Yang M, Liu L. Variations in the Wnt\/beta-Catenin Pathway Key Genes as Predictors of Cervical Cancer Susceptibility. PHARMACOGEN PERS MED. 2020;13:157\u201365.","journal-title":"PHARMACOGEN PERS MED"},{"key":"3432_CR49","first-page":"1745","volume":"20","author":"H Liu","year":"2016","unstructured":"Liu H, Wang YJ, Bian L, Fang ZH, Zhang QY, Cheng JX. CD44+\/CD24+ cervical cancer cells resist radiotherapy and exhibit properties of cancer stem cells. EUR REV MED PHARMACO. 2016;20:1745\u201354.","journal-title":"EUR REV MED PHARMACO"},{"key":"3432_CR50","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s00432-024-05799-y","volume":"150","author":"J Li","year":"2024","unstructured":"Li J, Hou F, Teng Z, Xia W, Peng J. LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B. J CANCER RES CLIN. 2024;150:294.","journal-title":"J CANCER RES CLIN"},{"key":"3432_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2017.01.006","volume":"171","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, An Q, Guo RX, Qiao YH, Li LX, Zhang XY, Zhao XL. miR424-5p functions as an anti-oncogene in cervical cancer cell growth by targeting KDM5B via the Notch signaling pathway. LIFE SCI. 2017;171:9\u201315.","journal-title":"LIFE SCI"},{"key":"3432_CR52","doi-asserted-by":"crossref","unstructured":"Zhu Y, Yang W, Wang X, Chen M. AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer. Int J Oncol. 2024;65(5):107.","DOI":"10.3892\/ijo.2024.5695"},{"key":"3432_CR53","doi-asserted-by":"publisher","first-page":"110077","DOI":"10.1016\/j.isci.2024.110077","volume":"27","author":"H Fei","year":"2024","unstructured":"Fei H, Chen T, Jiang H. Autocrine and paracrine effects of MDK promote lymph node metastasis of cervical squamous cell carcinoma. ISCIENCE. 2024;27: 110077.","journal-title":"ISCIENCE"},{"key":"3432_CR54","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s12253-020-00816-0","volume":"26","author":"K Karaszi","year":"2020","unstructured":"Karaszi K, Vigh R, Mathe M, Fullar A, Olah L, Fule T, Papp Z, Kovalszky I. Aberrant Expression of Syndecan-1 in Cervical Cancers. PATHOL ONCOL RES. 2020;26:2255\u201364.","journal-title":"PATHOL ONCOL RES"},{"key":"3432_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3802\/jgo.2011.22.3.161","volume":"22","author":"YI Kim","year":"2011","unstructured":"Kim YI, Lee A, Lee BH, Kim SY. Prognostic significance of syndecan-1 expression in cervical cancers. J GYNECOL ONCOL. 2011;22:161\u20137.","journal-title":"J GYNECOL ONCOL"},{"key":"3432_CR56","doi-asserted-by":"publisher","first-page":"803899","DOI":"10.3389\/fonc.2022.803899","volume":"12","author":"K Hilgers","year":"2022","unstructured":"Hilgers K, Ibrahim SA, Kiesel L, Greve B, Espinoza-Sanchez NA, Gotte M. Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells. FRONT ONCOL. 2022;12: 803899.","journal-title":"FRONT ONCOL"},{"key":"3432_CR57","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3389\/fgene.2020.00725","volume":"11","author":"H Ding","year":"2020","unstructured":"Ding H, Fan GL, Yi YX, Zhang W, Xiong XX, Mahgoub OK. Prognostic Implications of Immune-Related Genes\u2019 (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer. FRONT GENET. 2020;11:725.","journal-title":"FRONT GENET"},{"key":"3432_CR58","doi-asserted-by":"publisher","first-page":"979884","DOI":"10.3389\/fonc.2022.979884","volume":"12","author":"S Jiang","year":"2022","unstructured":"Jiang S, Zhou Y, Ye M, Li X, Zhang L, Yang Y. Construction of an immune-related ceRNA network in cervical cancer based on HPV E6 splicing. FRONT ONCOL. 2022;12: 979884.","journal-title":"FRONT ONCOL"},{"key":"3432_CR59","doi-asserted-by":"publisher","first-page":"831561","DOI":"10.3389\/fcvm.2022.831561","volume":"9","author":"F Yin","year":"2022","unstructured":"Yin F, Zhang H, Guo P, Wu Y, Zhao X, Li F, Bian C, Chen C, Han Y, Liu K. Comprehensive Analysis of Key m6A Modification Related Genes and Immune Infiltrates in Human Aortic Dissection. FRONT CARDIOVASC MED. 2022;9: 831561.","journal-title":"FRONT CARDIOVASC MED"},{"key":"3432_CR60","first-page":"6008","volume":"16","author":"Y Ye","year":"2024","unstructured":"Ye Y, Dai L, Mugaanyi J, Fu W, Hu F. Novel insights into the pathogenesis of thyroid eye disease through ferroptosis-related gene signature and immune infiltration analysis. Aging (Albany NY). 2024;16:6008\u201334.","journal-title":"Aging (Albany NY)"},{"key":"3432_CR61","doi-asserted-by":"publisher","first-page":"717084","DOI":"10.3389\/fsurg.2021.717084","volume":"8","author":"H Zheng","year":"2021","unstructured":"Zheng H, Liu H, Lu Y, Li H. Identification of a Novel Signature Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma. FRONT SURG. 2021;8: 717084.","journal-title":"FRONT SURG"},{"key":"3432_CR62","doi-asserted-by":"publisher","first-page":"2190618","DOI":"10.1080\/07853890.2023.2190618","volume":"55","author":"Y Wang","year":"2023","unstructured":"Wang Y, Mao Y, Wang C, Jiang X, Tang Q, Wang L, Zhu J, Zhao M. RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer. ANN MED. 2023;55:2190618.","journal-title":"ANN MED"},{"key":"3432_CR63","doi-asserted-by":"publisher","first-page":"e0081523","DOI":"10.1128\/jvi.00815-23","volume":"97","author":"S Mori","year":"2023","unstructured":"Mori S, Ishii Y, Takeuchi T, Kukimoto I. Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1. J VIROL. 2023;97: e0081523.","journal-title":"J VIROL"},{"key":"3432_CR64","doi-asserted-by":"publisher","first-page":"36591","DOI":"10.18632\/oncotarget.16619","volume":"8","author":"SS Saha","year":"2017","unstructured":"Saha SS, Chowdhury RR, Mondal NR, Roy S, Sengupta S. Expression signatures of HOX cluster genes in cervical cancer pathogenesis: Impact of human papillomavirus type 16 oncoprotein E7. Oncotarget. 2017;8:36591\u2013602.","journal-title":"Oncotarget"},{"key":"3432_CR65","doi-asserted-by":"publisher","first-page":"e24015","DOI":"10.1002\/jcla.24015","volume":"35","author":"F Ge","year":"2021","unstructured":"Ge F, Tie W, Zhang J, Zhu Y, Fan Y. Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer. J CLIN LAB ANAL. 2021;35: e24015.","journal-title":"J CLIN LAB ANAL"}],"updated-by":[{"DOI":"10.1186\/s13046-025-03597-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000}}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03432-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03432-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03432-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T08:01:33Z","timestamp":1764489693000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03432-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3432"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03432-5","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the authors identified error in the image of Fig. 12C where it was inadvertenty misused during figure preparation","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13046-025-03597-z","URL":"https:\/\/doi.org\/10.1186\/s13046-025-03597-z","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocols were performed according to Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}